Age-related differences in patient preferences for adjuvant chemotherapy for high-risk endometrial cancer
There is more heterogeneity in the desired benefit of chemotherapy among patients aged 70 years or more compared to younger patients. This underlines the importance of recognizing individual differences and the need for shared decision-making.
Authors
- Jannet C. Beukema
- Judith R. Kroep (ORCID: https://orcid.org/0000-0003-2671-1903)
- Cor D. de Kroon (ORCID: https://orcid.org/0000-0002-7999-4161)
- Cathalijne Post (ORCID: https://orcid.org/0000-0003-2534-6887)
- Arwen H. Pieterse (ORCID: https://orcid.org/0000-0001-6395-0052)
- Mandy Kiderlen
- Ina M. Jürgenliemk‐Schulz (ORCID: https://orcid.org/0000-0003-4911-006X)
- Ludy Lutgens (ORCID: https://orcid.org/0000-0002-2942-8858)
- Marianne A. A. de Jong
- Ellen M.A. Roeloffzen
- Hans W. Nijman (ORCID: https://orcid.org/0000-0002-1821-3042)
- Jan Willem Mens (ORCID: https://orcid.org/0000-0002-6363-8410)
- Jeltsje S. Cnossen
- Marie A.D. Haverkort (ORCID: https://orcid.org/0000-0001-6516-1380)
- Famke C. Wakkerman (ORCID: https://orcid.org/0009-0001-0930-724X)
- Carien L. Creutzberg (ORCID: https://orcid.org/0000-0002-7008-4321)
- Nanda Horeweg (ORCID: https://orcid.org/0000-0002-8581-4753)
- An Snyers
- Eva E. Schaake
- Friederike Koppe
Institutions
- University Medical Center Groningen (NL)
- Radboud University Nijmegen (NL)
- Utrecht University (NL)
- Leiden University Medical Center (NL)
- Catharina Ziekenhuis (NL)
- Radboud University Medical Center (NL)
- University Medical Center Utrecht (NL)
- Medisch Centrum Haaglanden (NL)
- Oncode Institute (NL)
- Instituut Verbeeten (NL)
- Radiotherapiegroep (NL)
- Isala (NL)
- Erasmus MC Cancer Institute (NL)
- Radiotherapeutisch Instituut Friesland (NL)
- Maastro Clinic (NL)
Publication Details
- Journal
- Maturitas
- Published
- 2025-12-02
- DOI
- https://doi.org/10.1016/j.maturitas.2025.108805
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00